Estrella
Martín Mazuelos
Publikationen, an denen er mitarbeitet Estrella Martín Mazuelos (24)
2022
-
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Frontiers in Cellular and Infection Microbiology, Vol. 12
2013
-
Incidencia etaria y geográfica y patrón de sensibilidad a los antifúngicos de las especies de Candida causantes de candidemia en la población pediátrica española
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 6, pp. 363-368
2012
-
Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187
2011
-
Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: Results from the FUNGEMYCA study.
Revista Iberoamericana de Micologia, Vol. 28, Núm. 2, pp. 91-99
-
Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients
BMC Infectious Diseases, Vol. 11
-
Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454
-
Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia
Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596
-
Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update
Enfermedades Infecciosas y Microbiologia Clinica
2010
2009
-
Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients
Clinical Microbiology and Infection, Vol. 15, Núm. 6, pp. 592-595
2007
-
Update on invasive fungal infections: the last two years
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 19-27
2004
-
In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts
Revista Iberoamericana de Micologia, Vol. 21, Núm. 2, pp. 63-69
2002
2001
-
Estudio epidemiológico de la criptococosis en España: Primeros resultados
Revista Iberoamericana de Micologia, Vol. 18, Núm. 3, pp. 99-104
-
Evaluación micológica de un nuevo medio de cultivo cromógeno (Candida ID®) para el aislamiento e identificación presuntiva de Candida albicans y otras levaduras de interés médico
Revista Iberoamericana de Micologia, Vol. 18, Núm. 1, pp. 23-28
2000
-
Actividad in vitro de una formulacion liposomica de nistatina (Nyotran®) frente a Cryptococcus neoformans
Revista Iberoamericana de Micologia, Vol. 17, Núm. 3, pp. 90-92
-
Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole
Chemotherapy, Vol. 46, Núm. 4, pp. 235-244
-
In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 19, Núm. 8, pp. 645-648
-
In vitro susceptibility of Candida dubliniensis to current and new antifungal agents
Chemotherapy, Vol. 46, Núm. 6, pp. 395-401
-
Sensibilidad a fluconazol e itraconazol en aislamientos de Candida spp. procedentes de pacientes VIH positivos y VIH negativos
Revista Espanola de Quimioterapia, Vol. 13, Núm. 1, pp. 60-63